XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 20,679 $ 26,211
Restricted cash 495 495
Accounts receivable, net of credit loss of $299 and $356, respectively 16,922 15,575
Contract assets 7,293 8,402
Inventory 31,954 28,905
Prepaid expenses 4,088 4,612
Other current assets 513 922
Assets held for sale 3,871 7,264
Total current assets 85,815 92,386
Property, plant, and equipment, net 14,605 15,517
Operating lease right-of-use assets 20,857 21,564
Other intangible assets, net 11,751 12,245
Other non-current assets 2,159 2,201
Total assets 135,187 143,913
Current liabilities:    
Accounts payable 12,357 9,683
Accrued expenses and other current liabilities 8,880 8,471
Contract liabilities 1,894 1,630
Financing payable 184 460
Loan payable - current 852 852
Operating lease liabilities - current 3,093 3,033
Liabilities held for sale 356 4,662
Total current liabilities 27,616 28,791
Line of credit 4,650 6,418
Loan payable - non-current 3,117 3,330
Operating lease liabilities - non-current 20,101 20,882
Asset retirement obligations 4,255 4,194
Other long-term liabilities 8 8
Total liabilities 59,747 63,623
Commitments and contingencies
Shareholders’ equity:    
Common stock, no par value, 100,000 shares authorized; 84,209 shares issued and 77,302 shares outstanding as of December 31, 2023; 84,014 shares issued and 77,108 shares outstanding as of September 30, 2023 825,948 825,119
Treasury stock at cost; 6,906 shares as of December 31, 2023 and September 30, 2023 (47,721) (47,721)
Accumulated other comprehensive income 350 350
Accumulated deficit (703,137) (697,458)
Total shareholders’ equity 75,440 80,290
Total liabilities and shareholders’ equity $ 135,187 $ 143,913